EuroEspes, S.A. announces an Equity Buyback for 1,075,580 shares, representing 19.37% of its issued share capital.
December 01, 2014
Share
EuroEspes, S.A. (BME:EEP) announces a share repurchase program. Under the program, the company will repurchase up to 1,075,580 shares, representing 19.37% of the share capital. The company will repurchase its shares from Inversora Portichol S.L.
Euroespes SA is a Spain-based company engaged in the healthcare sector. The Company operates a medical center, which focuses on the prevention, diagnosis and treatment of central nervous system disorders, such as Alzheimer and Parkinson, and other common diseases. The Companyâs medical offer includes personalized treatment plans, genomic medicine, epigenetics, neuropsychology, neuro-ophthalmology, digital diagnosis, diagnostic imaging, clinical analysis and nursing services, among others. In addition, it provides pharmacogenetics services and Human Identification Genetics card, which identifies user's deoxyribonucleic acid (DNA) profile. The Company operates through a number of subsidiaries, such as in Euroespes Biotecnologia SA, Distribuidora de Productos SL and Ebiotec Pharma SL.
EUROESPES, S.A. 